Abnormally elevated blood pressure (hypertension, HT) is a major cause of premature death and a challenge worldwide, with an estimated number of >1 billion adults aged 30–79 years having hypertension, many of them unaware of being affected. Unfortunately, HT can be a symptom of various diseases with very different causes, making diagnostics difficult. The adrenal […]

Diagnostics using indirect immunofluorescence tests (IFA) cover a wide range of indications and therefore have long been the gold standard in the laboratory. However, despite the many diagnostic applications of this method, evaluating fluorescence patterns can be a real challenge. More than half of the specific patterns that can be found in the evaluation of

Press release, March 3rd 2025 Revvity, Inc. (NYSE: RVTY), today announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support the diagnosis of a measles virus infection or to determine the immune status against measles virus. EUROIMMUN’s Anti-Measles Virus ELISA 2.0 (IgG) is the first of several assays in development expanding EUROIMMUN’s

Well prepared for the flu season: diagnostics in the interest of public health At regular intervals, sometimes daily, the latest influenza figures are published. National health authorities around the world collect a variety of patient data. The data are compared with each other or with data from the previous week or from the same time